Efficacy and safety of lurasidone in adolescents with schizophrenia: Interim analysis at twelve months of a 24-month, open-label extension study

Authors
Category Primary study
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Year 2017
This article has no abstract
Epistemonikos ID: 4dc2c1a0892f777d30919310b3784776aabbcace
First added on: Feb 08, 2025